Peter, Cyril J <br/><br/>
In vivo epigenetic editing of Sema6a promoter reverses transcallosal dysconnectivity caused by C11orf46/Arl14ep risk gene.  [electronic resource] 

 -  Nature communications  09 2019 
 - 4112 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, N.I.H., Intramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>2041-1723 
<br/><br/><label>Standard No.: </label>10.1038/s41467-019-12013-y  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adaptor Proteins, Vesicular Transport--genetics<br/>Animals<br/>Axons--metabolism<br/>Corpus Callosum--metabolism<br/>Epigenesis, Genetic<br/>Epigenome<br/>Gene Editing<br/>Gene Expression Regulation<br/>Genetic Predisposition to Disease<br/>HEK293 Cells<br/>Histone-Lysine N-Methyltransferase<br/>Humans<br/>Mice, Inbred C57BL<br/>Nerve Net--metabolism<br/>Neurites--metabolism<br/>Nuclear Proteins--metabolism<br/>Phenotype<br/>Promoter Regions, Genetic<br/>Protein Binding<br/>Protein Methyltransferases--metabolism<br/>Semaphorins--genetics